Adding Sleep Intervention to Traditional Diet and Exercise Approach to Weight Loss

NCT ID: NCT01135342

Last Updated: 2023-02-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-07-31

Study Completion Date

2010-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal is to determine if improved sleep will increase/enhance weight loss among overweight adults with insomnia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The major purpose of this study is to examine the effect of sleep quality and quantity on weight loss. The outcomes being studied are weight loss and improved sleep. The subjects being studied are those with body mass index 28-40kg/m2 who report sleeping less than 6.5 hours per day for 4 day per week or more for the past 6 months or longer and would likely benefit the most from the sleep intervention should it prove to be effective. We hope to learn if improved sleep habits among overweight adults with insomnia will help them to adhere to a diet and exercise program and increase their success with weight loss. Given the current world-wide obesity epidemic and the established difficulties many people have with weight control, any approaches that can be demonstrated to contribute to successful weight loss have direct public health significance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Initiation and Maintenance Disorders Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diet & Exercise plus Sleep Intervention

Diet and exercise instruction to promote weight loss plus cognitive behavioral therapy for insomnia.

Group Type EXPERIMENTAL

Diet and exercise

Intervention Type BEHAVIORAL

Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)

Cognitive Behavioral Therapy

Intervention Type BEHAVIORAL

Standardized cognitive behavioral therapy for insomnia (8 classes)

Diet & Exercise plus Passion and Balance

Diet and exercise instruction to promote weight loss plus sessions that are of general interest, but unrelated to diet, exercise, or sleep.

Group Type SHAM_COMPARATOR

Diet and exercise

Intervention Type BEHAVIORAL

Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)

Passion and Balance

Intervention Type BEHAVIORAL

Attention-match sessions of general interest, but unrelated to diet, exercise, or sleep (8 sessions)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet and exercise

Standardized instruction to eat less and exercise more to create an energy balance deficit to promote weight loss (16 classes)

Intervention Type BEHAVIORAL

Cognitive Behavioral Therapy

Standardized cognitive behavioral therapy for insomnia (8 classes)

Intervention Type BEHAVIORAL

Passion and Balance

Attention-match sessions of general interest, but unrelated to diet, exercise, or sleep (8 sessions)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Gender: Both women and men
* Age: \> or = 18 years
* Ethnicity and race: All ethnic and racial backgrounds welcome
* The following, which will be measured at the screening clinic visit:

* Body Mass Index: 28-40 (kg/m-squared)
* Chronic Short Sleep: total sleep time \< 6.5 hours, greater than or equal to 4 days per week (determined by 1-week sleep log) for the past 6 months or longer (based on self-report).
* Insomnia: sleep latency and/or wake after sleep onset \> 30 minutes, greater than or equal to 4 days per week, insomnia severity index \> 10, and complaint of at least one negative effect during waking hours (such as fatigue, sleepiness, impaired functioning, mood disturbance) attributed to sleep (as determined by self report).
* Eligible sleep disorder: sleep apnea or upper airway resistance syndrome treated by positive airway therapy for \> or = 3 months resulting in improved sleep.
* Psychiatric disorders that are stable on SSRI, SNRI, or bupropion antidepressant for greater than or equal to 3 months if no anticipated changes in medications to occur during the trial if they are weight stable.
* Planning to be available for clinic visits and for the 8 weeks of study participation
* Ability and willingness to give written informed consent.

Exclusion Criteria

* Sleep apnea (apnea-hypopnea index \> 15/hr) determined by portable sleep diagnostic system Periodic limb movements during sleep (PLM with arousal index \> 15/hr) determined by polysomnography.
* Any suspected sleep disorders identified by the Global Sleep Assessment Questionnaire, including circadian rhythm disorders (including shift work), parasomnias, narcolepsy, and restless leg.
* Self reported personal history of:
* DSM-IV Axis-I and Axis-II diagnoses (i.e. eating disorders, bi-polar disorder, schizophrenia and other psychotic disorders, substance-related disorders, personality disorders, poorly controlled major depression and anxiety disorders determined by SCID) except those allowed under Inclusions.
* Subjects currently receiving the following medications known to affect sleep(self report):

* sedative hypnotics
* sedative antidepressants
* systemic steroids
* anticonvulsants
* histamine-1
* receptor antagonists
* narcotic analgesics
* CNS stimulants
* Body Mass Index (BMI) greater than 40.
* Pregnant, Lactating, or \<6 months post-partum.
* Inability to communicate effectively with study personnel.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christopher Gardner

Professor of Medicine (Research)

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher D Gardner

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University School of Medicine

Stanford, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R21HL092268-01A2

Identifier Type: NIH

Identifier Source: secondary_id

View Link

SU-05062010-5883

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cognitive Behavioural Therapy for Obesity
NCT00294268 COMPLETED PHASE2
Women's Lifestyle Balance Study
NCT03184337 COMPLETED NA